XITO 10-Q
Xenous Holdings, Inc. (XITO)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended
TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT |
For the transition period from ____________ to ______________
Commission file number:
(Exact name of registrant as specified in its charter) |
| ||
(State or other jurisdiction of incorporation or organization) |
| (IRS Employer Identification No.) |
(Address of principal executive offices)
+
(Registrant’s telephone number)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class: |
| Trading Symbol(s) |
| Name of each exchange on which registered: |
|
| OTC Pink Sheets |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer | ☐ | Accelerated filer | ☐ |
☐ | Smaller reporting company | ||
(Do not check if a smaller reporting company) | Emerging growth company | ||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes
The number of shares of the issuer’s common stock outstanding as of February 4, 2025 was
XENOUS HOLDINGS, INC.
FORM 10-Q
Quarterly Period Ended December 31, 2024
INDEX
|
| Page | ||
|
|
| ||
PART I. FINANCIAL INFORMATION |
|
| ||
|
|
|
|
|
| 3 |
| ||
| Balance Sheets as of December 31, 2024 (unaudited) and March 31, 2024 (audited) |
| 3 |
|
|
| 4 |
| |
|
| 5 |
| |
| Statements of Cash Flows for the Nine Months ended December 31, 2024 and 2023 (unaudited) |
| 6 |
|
|
| 7 |
| |
Management’s Discussion and Analysis of Financial Condition and Results of Operations |
| 10 |
| |
| 12 |
| ||
| 12 |
| ||
|
|
| ||
|
| |||
|
|
|
| |
| 13 |
| ||
| 13 |
| ||
| 13 |
| ||
| 13 |
| ||
| 13 |
| ||
| 13 |
| ||
| 13 |
| ||
|
|
| ||
| 14 | |||
| 2 |
| Table of Contents |
Item 1. Financial Statements
XENOUS HOLDINGS, INC.
Balance Sheets
|
| December 31, 2024 |
|
| March 31, 2024 |
| ||
|
| (Unaudited) |
|
| (Audited) |
| ||
ASSET |
|
|
|
|
|
| ||
|
|
|
|
|
|
| ||
TOTAL ASSET |
| $ |
|
| $ |
| ||
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS' DEFICIT |
|
|
|
|
|
|
|
|
Current Liabilities |
|
|
|
|
|
|
|
|
Accounts payable and accrued liabilities |
| $ |
|
| $ |
| ||
Due to a related party |
|
|
|
|
|
| ||
Total Current Liabilities |
|
|
|
|
|
| ||
|
|
|
|
|
|
|
|
|
TOTAL LIABILITIES |
|
|
|
|
|
| ||
|
|
|
|
|
|
|
|
|
STOCKHOLDERS' DEFICIT |
|
|
|
|
|
|
|
|
Preferred stock, par value $ |
|
|
|
|
|
| ||
Common stock, par value $ |
|
|
|
|
|
| ||
Capital deficiency |
|
| ( | ) |
|
| ( | ) |
Accumulated deficit |
|
| ( | ) |
|
| ( | ) |
Total Stockholders' Deficit |
|
| ( | ) |
|
| ( | ) |
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT |
| $ |
|
| $ |
| ||
The accompanying notes are an integral part of these unaudited condensed financial statements.
| 3 |
| Table of Contents |
XENOUS HOLDINGS, INC.
Statements of Operations
(Unaudited)
|
| For the Three Months Ended |
|
| For the Nine Months Ended |
| ||||||||||
|
| December 31, |
|
| December 31, |
|
| December 31, |
|
| December 31, |
| ||||
|
| 2024 |
|
| 2023 |
|
| 2024 |
|
| 2023 |
| ||||
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
OPERATING EXPENSES |
|
|
|
|
|
|
|
|
|
|
|
| ||||
General and administrative |
| $ |
|
| $ |
|
| $ |
|
| $ |
| ||||
Professional fees |
|
|
|
|
|
|
|
|
|
|
|
| ||||
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NET LOSS |
| $ | ( | ) |
| $ | ( | ) |
| $ | ( | ) |
| $ | ( | ) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and Diluted Loss per Common Share |
| $ | ( | ) |
| $ | ( | ) |
| $ | ( | ) |
| $ | ( | ) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and Diluted Weighted Average Number of Common Shares |
|
|
|
|
|
|
|
|
|
|
|
| ||||
The accompanying notes are an integral part of these unaudited condensed financial statements.
| 4 |
| Table of Contents |
XENOUS HOLDINGS, INC.
Statements of Changes in Stockholders’ Deficit
For the nine months ended December 31, 2024 and 2023
(Unaudited)
Nine Months Ended December 31, 2024
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||
|
| Common Stock |
|
|
|
|
|
| Total |
| ||||||||||
|
| Number of Shares |
|
| Amount |
|
| Capital Deficiency |
|
| Accumulated Deficit |
|
| Stockholders' Deficit |
| |||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||
Balance - March 31, 2024 |
|
|
|
| $ |
|
| $ | ( | ) |
| $ | ( | ) |
| $ | ( | ) | ||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
| - |
|
|
|
|
|
|
|
|
| ( | ) |
|
| ( | ) | ||
Balance - June 30, 2024 |
|
|
|
| $ |
|
| $ | ( | ) |
| $ | ( | ) |
| $ | ( | ) | ||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
| - |
|
|
|
|
|
|
|
|
| ( | ) |
|
| ( | ) | ||
Balance - September 30, 2024 |
|
|
|
| $ |
|
| $ | ( | ) |
| $ | ( | ) |
| $ | ( | ) | ||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
| - |
|
|
|
|
|
|
|
|
| ( | ) |
|
| ( | ) | ||
Balance - December 31, 2024 |
|
|
|
| $ |
|
| $ | ( | ) |
| $ | ( | ) |
| $ | ( | ) | ||
Nine Months Ended December 31, 2023
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||
|
| Common Stock |
|
|
|
|
|
| Total |
| ||||||||||
|
| Number of Shares |
|
| Amount |
|
| Capital Deficiency |
|
| Accumulated Deficit |
|
| Stockholders' Deficit |
| |||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||
Balance - March 31, 2023 |
|
|
|
| $ |
|
| $ | ( | ) |
| $ | ( | ) |
| $ | ( | ) | ||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
| - |
|
|
|
|
|
|
|
|
| ( | ) |
|
| ( | ) | ||
Balance - June 30, 2023 |
|
|
|
| $ |
|
| $ | ( | ) |
| $ | ( | ) |
| $ | ( | ) | ||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
| - |
|
|
|
|
|
|
|
|
| ( | ) |
|
| ( | ) | ||
Balance - September 30, 2023 |
|
|
|
| $ |
|
| $ | ( | ) |
| $ | ( | ) |
| $ | ( | ) | ||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
| - |
|
|
|
|
|
|
|
|
| ( | ) |
|
| ( | ) | ||
Balance - December 31, 2023 |
|
|
|
| $ |
|
| $ | ( | ) |
| $ | ( | ) |
| $ | ( | ) | ||
The accompanying notes are an integral part of these unaudited condensed financial statements.
| 5 |
| Table of Contents |
XENOUS HOLDINGS, INC.
Statements of Cash Flows
(Unaudited)
|
| For the Nine Months Ended |
| |||||
|
| December 31, |
|
| December 31, |
| ||
|
| 2024 |
|
| 2023 |
| ||
|
|
|
|
|
|
| ||
CASH FLOWS FROM OPERATING ACTIVITIES |
|
|
|
|
|
| ||
Net loss |
| $ | ( | ) |
| $ | ( | ) |
Changes in operating assets and liabilities: |
|
|
|
|
|
|
|
|
Accounts payable and accrued liabilities |
|
| ( | ) |
|
|
| |
Net cash used in operating activities |
|
| ( | ) |
|
| ( | ) |
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM FINANCING ACTIVITY |
|
|
|
|
|
|
|
|
Proceeds from related party advances |
|
|
|
|
|
| ||
Net cash provided by financing activity |
|
|
|
|
|
| ||
|
|
|
|
|
|
|
|
|
Net changes in cash and cash equivalents |
|
|
|
|
|
| ||
Cash and cash equivalents - beginning of period |
|
|
|
|
|
| ||
Cash and cash equivalents - end of period |
| $ |
|
| $ |
| ||
|
|
|
|
|
|
|
|
|
Supplemental Cash Flow Disclosures |
|
|
|
|
|
|
|
|
Cash paid for interest |
| $ |
|
| $ |
| ||
Cash paid for income taxes |
| $ |
|
| $ |
| ||
The accompanying notes are an integral part of these unaudited condensed financial statements.
| 6 |
| Table of Contents |
XENOUS HOLDINGS, INC.
Notes to the Unaudited Condensed Financial Statements
December 31, 2024
NOTE 1 - NATURE OF BUSINESS AND CONTINUANCE OF OPERATIONS
Xenous Holdings, Inc. (the “Company”) was incorporated on May 20, 1980 as Dayne Weiss and Associates, Inc. under the laws of the State of Utah.
On December 19, 2014, the Company completed a change of domicile merger with Concept Holding Corp., a Nevada corporation, which became the surviving entity.
On July 21, 2017, the Board of Directors of the Company elected to file Articles of Merger with the Nevada SOS whereby it would enter into a statutory merger with its wholly-owned subsidiary, M101 Corp., a Nevada corporation, pursuant to Nevada Revised Statutes 92A.200, et seq. The effect of such merger is the Company is the surviving entity and changed its name to “M101 Corp.” The merger took effect on August 14, 2017.
On November 2, 2019, a majority of shareholders approved a resolution to change the name of the Company to Xenous Holdings, Inc. On November 19, 2019, the Company received notice that the Secretary of State of Nevada accepted the Company’s Certificate of Amendment to its Articles of Incorporation to change the name of the Company to Xenous Holdings, Inc. The Company currently has no business operations.
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The accompanying unaudited condensed financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. Operating results for the nine months ended December 31, 2024 are not necessarily indicative of the results that may be expected for the year ending March 31, 2025. The notes to the unaudited financial statements are condensed, as disclosures that would substantially duplicate the disclosures contained in the audited financial statements for fiscal year 2024 have been omitted. This report should be read in conjunction with the audited financial statements and the footnotes thereto for the fiscal year ended March 31, 2024 included in the Company’s Form 10-K as filed with the Securities and Exchange Commission on June 27, 2024.
Use of Estimates
The Company prepares its financial statements in conformity with “GAAP,” which require management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Fair Value of Financial Instruments
ASC 820 “Fair Value Measurements and Disclosures” establishes a three-tier fair value hierarchy, which prioritizes the inputs in measuring fair value. The hierarchy prioritizes the inputs into three levels based on the extent to which inputs used in measuring fair value are observable in the market.
These tiers include:
Level 1: defined as observable inputs such as quoted prices in active markets;
Level 2: defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and
Level 3: defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions.
The Company’s financial instruments consist primarily of accounts payable and debts. The carrying amounts of such financial instruments approximate their respective estimated fair value due to the short-term maturities and approximate market interest rates of these instruments.
| 7 |
| Table of Contents |
Basic and Diluted Earnings Per Share
The Company has adopted ASC Topic 260, ”Earnings per Share,”(“EPS”) which requires presentation of basic EPS on the face of the income statement for all entities with complex capital structures and requires a reconciliation of the numerator and denominator of the basic EPS computation. In the accompanying financial statements, basic earnings (loss) per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period.
As of December 31, 2024 and 2023, the Company did not have any potentially dilutive securities.
Related Parties
We follow ASC 850,“Related Party Disclosures” for the identification of related parties and disclosure of related party transactions. (see Note 4).
Recently Issued Accounting Pronouncements
The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoption of any such pronouncements may be expected to cause a material impact on its financial condition or the results of its operations.
In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740) - Improvements to Income Tax Disclosures ("ASU 2023-09"), which is intended to enhance the transparency and decision usefulness of income tax disclosures. The amendments in ASU 2023-09 provide for enhanced income tax information primarily through changes to the rate reconciliation and income taxes paid information. ASU 2023-09 is effective for the Company prospectively to all annual periods beginning after December 15, 2024. Early adoption is permitted. We are currently evaluating the impact this update will have on our unaudited condensed consolidated financial statements and disclosures.
In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280) - Improvements to Reportable Segment Disclosures ("ASU 2023-07"), which require public companies disclose significant segment expenses and other segment items on an annual and interim basis and to provide in interim periods all disclosures about a reportable segment's profit or loss and assets that are currently required annually. The guidance is effective for public entities for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The guidance is applied retrospectively to all periods presented in the financial statements, unless it is impracticable. We do not believe that this accounting pronouncement will have any material impact on our financial statements or disclosures upon adoption.
NOTE 3 - GOING CONCERN
The Company has not yet generated any revenue since its inception and has an operating loss and net loss of $
The accompanying financial statements have been prepared assuming that the Company will continue as a going concern; however, the above conditions raise substantial doubt about the Company’s ability to do so. The financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result should the Company be unable to continue as a going concern.
While we believe in the viability of our strategy to generate sufficient revenues in the future and in our ability to raise additional funds, there can be no assurances to that effect.
| 8 |
| Table of Contents |
NOTE 4 - RELATED PARTY TRANSACTIONS
Due to Related Party
During the nine months ended December 31, 2024 and 2023, Smartex Investment Ltd., the majority shareholder of the Company which is holding
NOTE 5 – SHARE CAPITAL
Preferred Stock
The Company is authorized to issue
Common Stock
The Company is authorized to issue
There were no stock issuances during the nine months ended December 31, 2024 and 2023. As of December 31, 2024 and March 31, 2024, the Company had
NOTE 6 – SUBSEQUENT EVENTS
In accordance with ASC 855-10, the Company has analyzed its operations subsequent to December 31, 2024 to the date these financial statements were issued and has determined that it does not have other material subsequent events to disclose in these financial statements except as stated below:
In November 2022, the Company announced that it was conducting a full financial and legal due diligence of a Malaysia-based company involving the plantations, inoculations, cultivations, manufacturing, marketing, trading and conducting research and development of agricultural commodities in relation to Aquilaria trees and its related products. The preliminary due diligence for its target acquisition company has been successfully completed. This critical first phase has yielded a positive outcome, confirming our confidence in the potential value of the target company. The Company is now progressing with further due diligence, specifically focusing on the intangible assets and the valuation of these assets. This thorough assessment is essential to ensure a comprehensive evaluation of the acquisition target. The due diligence process is expected to be completed by the first half of calendar year 2025. Following the successful conclusion of this final phase, the acquisition will proceed formally, in line with our previous announcements. The Company remains committed to transparency and will continue to keep stakeholders informed of any significant developments. We appreciate the ongoing support from our investors, partners, and customers as we move forward with this strategic acquisition.
| 9 |
| Table of Contents |
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND RESULTS OF OPERATIONS.
When used in this Quarterly Report, the words “may,” “will,” “expect,” “anticipate,” “continue,” “estimate,” “project,” “intend,” and similar expressions are intended to identify forward-looking statements regarding events, conditions, and financial trends that may affect our future plans of operations, business strategy, operating results, and financial position. Persons reviewing this Quarterly Report are cautioned that any forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties and actual results may differ materially from those included within the forward-looking statements as a result of various factors. Such factors are discussed further below and also include general economic factors and conditions that may directly or indirectly impact our financial condition or results of operations.
Plan of Operation
Our plan of operation for the next 12 months is to: (i) consider guidelines of industries in which we may have an interest; (ii) adopt a business plan regarding engaging in the business of any selected industry; and (iii) to commence such operations through funding and/or the acquisition of a “going concern” engaged in any industry selected.
During the next 12 months, our only foreseeable cash requirements will relate to maintaining our good standing or the payment of expenses associated with legal fees, accounting fees and reviewing or investigating any potential business venture, which may be advanced by management or principal stockholders as loans to us. Because we have not determined any business or industry in which our operations will be commenced, and we have not identified any prospective venture as of the date of this Annual Report, it is impossible to predict the amount of any such loan. Any such loan will be on terms no less favorable to us than would be available from a commercial lender in an arm’s length transaction. No advance or loan from any affiliate will be required to be repaid as a condition to any agreement with future acquisition partners.
Results of Operations
Three Months Ended December 31, 2024 and 2023
|
| Three Months |
|
| Three Months |
|
|
|
| |||
|
| Ended |
|
| Ended |
|
|
|
| |||
|
| December 31, |
|
| December 31, |
|
|
|
| |||
|
| 2024 |
|
| 2023 |
|
| Changes |
| |||
|
|
|
|
|
|
|
|
|
| |||
Operating Expenses |
| $ | 14,894 |
|
| $ | 14,923 |
|
| $ | (29 | ) |
Net Loss |
| $ | (14,894 | ) |
| $ | (14,923 | ) |
| $ | 29 |
|
We had no operations during the three months ended December 31, 2024 or 2023, nor do we have operations as of the date of this filing. We had a net loss of $14,894 and $14,923 for the three months ended December 31, 2024 and 2023, respectively. The decrease in net loss was mainly attributable by the decrease in general and administrative.
Nine Months Ended December 31, 2024 and 2023
|
| Nine Months |
|
| Nine Months |
|
|
|
| |||
|
| Ended |
|
| Ended |
|
|
|
| |||
|
| December 31, |
|
| December 31, |
|
|
|
| |||
|
| 2024 |
|
| 2023 |
|
| Changes |
| |||
|
|
|
|
|
|
|
|
|
| |||
Operating Expenses |
| $ | 46,049 |
|
| $ | 45,462 |
|
| $ | 587 |
|
Net Loss |
| $ | (46,049 | ) |
| $ | (45,462 | ) |
| $ | (587 | ) |
We had no operations during the nine months ended December 31, 2024 or 2023, nor do we have operations as of the date of this filing. We had a net loss of $46,049 and $45,462 for the nine months ended December 31, 2024 and 2023, respectively. The increase in net loss was mainly attributable by the increase in professional fees.
| 10 |
| Table of Contents |
Liquidity and Capital Resources
|
| As of |
|
| As of |
|
|
|
| |||
|
| December 31, |
|
| March 31, |
|
|
|
| |||
|
| 2024 |
|
| 2024 |
|
| Changes |
| |||
|
|
|
|
|
|
|
|
|
| |||
Current Assets |
| $ | - |
|
| $ | - |
|
| $ | - |
|
Current Liabilities |
| $ | 885,215 |
|
| $ | 839,166 |
|
| $ | 46,049 |
|
Working Capital (Deficiency) |
| $ | (885,215 | ) |
| $ | (839,166 | ) |
| $ | (46,049 | ) |
As of December 31, 2024 and March 31, 2024, we had no current asset.
As of December 31, 2024 and March 31, 2024, our total liabilities were $885,215 and $839,166, respectively, which were current liabilities comprised of accounts payable, accrued liabilities, and related party advances.
Stockholders’ deficit was at $885,215 as of December 31, 2024, compared to deficit of $839,166 as of March 31, 2024.
We had no cash on hand as of December 31, 2024 or March 31, 2024 to meet ongoing expenses and debts that may accumulate. Accumulated deficit was at $1,196,015 as of December 31, 2024, compared to accumulated deficit of $1,149,966 as of March 31, 2024.
As of December 31, 2024, we had a working capital deficit of $885,215 compared with a working capital deficit of $839,166 as of March 31, 2024. The increase in working capital deficit was attributed to an increase in due to related party for advancement from the Company’s majority shareholder paying off vendors on behalf of the Company.
|
| Nine Months |
|
| Nine Months |
|
|
|
| |||
|
| Ended |
|
| Ended |
|
|
|
| |||
|
| December 31, |
|
| December 31, |
|
|
|
| |||
|
| 2024 |
|
| 2023 |
|
| Changes |
| |||
|
|
|
|
|
|
|
|
|
| |||
Net cash used in operating activities |
| $ | (49,057 | ) |
| $ | (40,168 | ) |
| $ | (8,889 | ) |
Net cash provided by financing activities |
| $ | 49,057 |
|
| $ | 40,168 |
|
| $ | 8,889 |
|
Net changes in cash and cash equivalents |
| $ | - |
|
| $ | - |
|
| $ | - |
|
Cash Flow from Operating Activities
We have not generated any positive cash flow from operating activities.
For the nine months ended December 31, 2024, net cash flows used in operating activities was $49,057. The net cash used in operating activities for the nine months ended December 31, 2024 was attributed by a net loss of $46,049, increased by a decrease in accounts payable and accrued liabilities of $3,008.
For the nine months ended December 31, 2023, net cash flows used in operating activities was $40,168. The net cash used in operating activities for the nine months ended December 31, 2023 was attributed by a net loss of $45,462, decreased by an increase in accounts payable and accrued liabilities of $5,294.
Cash Flow from Investing Activities
During the nine months ended December 31, 2024 and 2023, we had no investing activities.
Cash Flow from Financing Activities
We have financed our operations primarily from advances and loans from Smartex Investment Ltd., majority shareholder of the Company.
For the nine months ended December 31, 2024 and 2023, net cash from financing activities was $49,057 and $40,168, respectively.
| 11 |
| Table of Contents |
Going Concern
Our independent auditors have added an explanatory paragraph to their audit issued in connection with the financial statements for the year ended March 31, 2024, relative to our ability to continue as a going concern. The Company, which has not generated any revenues, has incurred net losses, has net current liabilities and a stockholders’ deficit. These conditions, among others, raise substantial doubt about the Company’s ability to continue as a going concern. The Company’s continuation as a going concern is dependent on its ability to meet its obligations, to obtain additional financing as may be required and ultimately to attain profitability. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
The Company is dependent on advances from its principal shareholders or other affiliated parties for continued funding. There are no commitments or guarantees from any third party to provide such funding nor is there any guarantee that the Company will be able to access the funding it requires to continue its operations.
Off-Balance Sheet Arrangements
We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to an investor in our securities.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Pursuant to Item 305(e) of Regulation of S-K (§229.305(e)), the Company is not required to provide the information required by this Item as it is a “smaller reporting company,” as defined by Rule 229.10(f)(1).
ITEM 4. CONTROLS AND PROCEDURES
Disclosure Controls and Procedures
Disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act) are designed to ensure that information required to be disclosed in reports filed or submitted under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in rules and forms adopted by the Securities and Exchange Commission, and that such information is accumulated and communicated to management, including the Chief Executive Officer and Secretary, to allow timely decisions regarding required disclosures.
Under the supervision and with the participation of our management, including our Chief Executive Officer and Secretary, we evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act) as of the end of the period covered by this Quarterly Report. Based upon that evaluation, our Chief Executive Officer and Secretary concluded that, as of the end of the period covered by this Quarterly Report, our disclosure controls and procedures were not effective.
Changes in Internal Control Over Financial Reporting
During the fiscal quarter covered by this Quarterly Report, there has been no change in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
| 12 |
| Table of Contents |
PART II – OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
Management is not aware of any legal proceedings contemplated by any governmental authority or any other party involving us. As of the date of this Quarterly Report, no director, officer or affiliate is (i) a party adverse to us in any legal proceeding, or (ii) has an adverse interest to us in any legal proceedings. Management is not aware of any other legal proceedings pending or that have been threatened against us.
ITEM 1A. RISK FACTORS
As a “smaller reporting company” as defined by Item 10 of Regulation S-K, the Company is not required to provide this information.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
There were no unregistered sales of our equity securities during the period covered by this quarterly report.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
None.
ITEM 4. MINE SAFETY DISCLOSURES
Not applicable.
ITEM 5. OTHER INFORMATION
None.
ITEM 6. EXHIBITS
Exhibits:
| Rule 13(a)-14(a)/15(d)-14(a) Certification of Chief Executive Officer | |
| Rule 13(a)-14(a)/15(d)-14(a) Certification of Chief Financial Officer | |
| ||
|
| 13 |
| Table of Contents |
SIGNATURES
In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| XENOUS HOLDINGS, INC. |
| |
|
|
| |
DATED: February 14, 2025 | By: | /s/ Jonathan Chan Ye Earn |
|
|
| Jonathan Chan Ye Earn |
|
|
| Chief Executive Officer (Principal Executive Officer) |
|
|
|
| |
| By: | /s/ Stephanie Mak |
|
|
| Stephanie Mak |
|
|
| Chief Financial Officer (Principal Financial Officer) |
|
| 14 |